Year: 2025
Type: article
Abstract: Natural killer (NK) cells are critical components of the first-line immune defense, responsible for eliminating tumorigenic cells. NK cell-based adoptive immunotherapy has gained increasing attention; however, cryopreservation, a standard technique for NK cell storage, significantly impairs NK cell cytotoxicity, particularly in physiological 3D environments. Here, we demonstrate that short-term co-culture with effector T cells markedly enhances NK cell motility and killing functionality. Notably, a brief 1-day co-culture is sufficient to restore cryopreservation-impaired NK cell functionality in 3D environments. This enhancement requires direct contact between T cells and NK cells, which facilitates localized high concentrations of IL-2 at the cell contact sites. To develop a controled, donor-independent solution, we demonstrate that synthetic T cells with surface-bound IL-2 exhibit superior efficiency in revitalizing cryopreserved NK cells. These findings uncover a previously unrecognized role for physical contact-mediated local IL-2 signaling and provide an efficient, cost-effective, and tunable strategy to rescue NK cell functionality post-cryopreservation, paving the way for more scalable, potent, and clinically viable NK cell-based immunotherapies.
Source: Advanced Science
Authors: Xiangda Zhou, Sijia Zhang, Wenjuan Yang, Susanne Gonder, Zeinab Sadjadi, Nils Piernitzki, Alina Moter, Shulagna Sharma, Anne Largeot, Nadja Küchler, Lea Kaschek, Gertrud Schäfer, Eva C. Schwarz, Hermann Eichler, Evelyn Ullrich, Heiko Rieger, Oskar Staufer, Jérôme Paggetti, Etienne Moussay, Markus Hoth, Bin Qu
Institutions: Second Military Medical University, Saarland University, Luxembourg Institute of Health, Leibniz-Institute for New Materials, Goethe University Frankfurt, Frankfurt Cancer Institute, Deutsches Konsortium für Translationale Krebsforschung, Helmholtz Institute for Pharmaceutical Research Saarland, Max Planck-Bristol Centre for Minimal Biology, Osnabrück University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,730
Awards: G106007106, G120701252, G1391827149, G1704993792, G1818335800, G1976032559, G2637305634, G3572836296, G4019468963, G505311720, SFB 1292: Gezielte Beeinflussung von konvergierenden Mechanismen ineffizienter Immunität bei Tumorerkrankungen und chronischen Infektionen, Analyse biophysikalischer Adaptionsmechanismen in der TumorImmunMikroumgebung mittels synthetischer Zellsysteme, G5712584538, G6404407014
OpenAlex ID: W4414320655
